Medical Updates

High Adherence to Antidepressants Associated with Reduction in All-cause Mortality in Cancer Patients

Treatment of depression and anxiety in cancer with antidepressants (AD) is shown to be effective however, the link between AD adherence and...

19 Aug, 2019

 
Email this page
Combination of ENCO+BINI+CETUX Shows Improvement in OS and ORR in Patients with BRAF V600E-mutant mCRC

The BEACON CRC Study was a multicenter, randomized, open-label, 3-arm, phase 3 study to evaluate encorafenib (ENCO) + cetuximab (CETUX) with/without...

16 Jul, 2019

 
Email this page
Combination of Enzalutamide and Cisplatin Effective in Urothelial Carcinoma of Bladder

A recent study detected androgen receptor (AR) expression in a significant percentage of male patients with muscle invasive bladder cancer (MIBC)....

12 Jul, 2019

 
Email this page
Predicting Chemotherapy Benefit with Combined Clinical and Genomic Risk in Breast Cancer Patients

Trial Assigning Individualized Options for Treatment (TAILORx), a prospective trial showed that endocrine therapy was non-inferior to chemoendocrine...

27 Jun, 2019

 
Email this page

eCMEs

Date: 22nd February 2020
Time: 2:00 pm to 3:30 pm
Date: 17th February 2020
Time: 3:00 pm to 4:00 pm

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Haematological Malignancies

Haematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. This slide set includes types, risk factors,...

 
Email this page

Key Trials

No Significant Changes in Lipid and Glucose Metabolism with Degarelix and Leuprolide Treatment in Prostate Cancer

There were no significant differences in the lipid and glucose metabolism in the patients of prostate cancer treated with degarelix and leuprolide...

Addition of Docetaxel to Androgen Deprivation Therapy Improves Survival Outcomes and is Cost-Effective in Metastatic Prostate Cancer

The survival outcomes associated with addition of docetaxel to androgen deprivation therapy (Doc-ADT) were superior compared to maximum androgen-...

Apalutamide Prolongs Survival in Metastatic Castration-Sensitive Prostate Cancer: Findings of TITAN Trial

Addition of enzalutamide to androgen deprivation therapy (ADT) significantly prolonged the overall survival and radiographic progression-free...

Outcomes of Treatment with Eribulin for Metastatic Triple-negative Breast Cancer in Real-World Clinical Setting

This is the first large study of eribulin use among real-world metastatic triple-negative breast cancer patients treated in the US. In this study,...

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Myths and Facts about Cancer

Throughout the years there have been many cancer myths floating around. This article will help clear the myths related to cancer.

Infographics

Explore >>

Currently there is no content under this category.

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
38% (3 votes)
Tegafur uracil
0% (0 votes)
5-FU
63% (5 votes)
Total votes: 8